Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Adv Exp Med Biol ; 840: 51-8, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25256339

RESUMEN

Standard exercise testing (ET) comprises progressive exercise provocation with cardiovascular monitoring. Exercise tolerance is estimated by workload. Cardiopulmonary exercise testing (CPX) is a non-invasive measurement of ventilatory gas exchange which provides more accurate quantifications of cardiorespiratory fitness (CRF). Workload is usually increased stepwise in ET and continuously (ramp) in CPX. Our aim was to examine the comparability of the results. Thirty two healthy volunteers (17 females/15 males, age 26.8±6.1 years, BMI 24.5±3.0) underwent exercise testing on a bicycle ergometer up to maximum physical exhaustion; under ramp protocol (CPX) and 2-7 days later with a stepwise increase of workload (ET). We compared the physical work capacity under both methods at maximum workload, at heart rate of 150 and 170 beats/min (PWC150 and PWC170), and the exercise duration. We found that there were no statistically significant differences in the maximum heart rate (CPX: 177.1±11.7/min vs. ET: 178.5±11.2/min) or maximal workload (CPX: 219.8±50.6 vs. ET: 209.4±42.5). PWC150 and PWC150/kg were higher with CPX than those with ET (156.6±51 vs. 146.4±42.3, p<0.001 and 2.1±0.5 vs. 1.9±0.4, respectively, p<0.001). Exercise duration was almost equal (12.1 vs. 11.3 min). We conclude that overall physical performance was higher with CPX. Since the results are similar, we recommend the CPX: wattage and other parameters in performance assessment are to be determined directly, interpolations are obsolete.


Asunto(s)
Umbral Anaerobio/fisiología , Prueba de Esfuerzo/métodos , Prueba de Esfuerzo/normas , Tolerancia al Ejercicio/fisiología , Ejercicio Físico/fisiología , Adulto , Femenino , Humanos , Masculino , Consumo de Oxígeno/fisiología , Resistencia Física/fisiología , Aptitud Física/fisiología , Factores Sexuales , Soporte de Peso/fisiología , Adulto Joven
2.
Pneumologie ; 66(8): 497-506, 2012 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-22875734

RESUMEN

Due to the current query whether the predominantly used chrysotile (white) asbestos comprises health risks we performed a literature search including in vitro and animal experiments as well as epidemiological studies.As shown by epidemiological studies chrysotile causes less pleural fibrosis and mesotheliomas when compared with other asbestos types. However, its otherwise inflammatory, toxic, carcinogenic, and fibrosis-inducing effects correspond to those of other occupationally relevant asbestos types. This is based on clinical, animal as well as on in-vitro findings. This means that denying a causal relationship, e. g. in a case with lung fibrosis (= asbestosis) or lung cancer with an asbestos load of 25 fiber-years in the absence of identification of a significant concentration of asbestos fibers or asbestos bodies in the lung (see so-called "hit and run" phenomenon), contradicts the medical-scientific knowledge.


Asunto(s)
Asbestos Anfíboles/envenenamiento , Asbestos Serpentinas/envenenamiento , Asbestosis/etiología , Asbestosis/mortalidad , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/mortalidad , Medicina Basada en la Evidencia , Humanos , Descubrimiento del Conocimiento , Prevalencia , Factores de Riesgo , Análisis de Supervivencia , Tasa de Supervivencia
3.
Gesundheitswesen ; 72(8-9): e38-44, 2010.
Artículo en Alemán | MEDLINE | ID: mdl-19795341

RESUMEN

AIM: The aim of this systematic review was to analyse the effects of gatekeeping where primary care physicians (PCP) control access to specialist care. METHODS: Literature search in Medline, EMBASE, Cochrane Library, and a hand search were carried out. INCLUSION CRITERIA: (1) intervention: gatekeeping by PCP compared to free access to specialist care; (2) outcomes: health outcomes, health related quality of life, quality of care, utilization of care, costs, satisfaction of patients and providers; (3) design: RCT, quasi-random. CT, CBA, cohort and case control studies, ITS. Data extraction and assessment was done by two independent reviewers according to Cochrane EPOC-Group and USTFCPS. RESULTS: 24 included studies (1989-2007) were as follows: 1 RCT, 2 quasi-randomised CT, 3 prospective, and 12 retrospective cohort studies, 4 CBA, and 2 ITS. 67% of the studies analysed data from the USA, the remaining from CH, UK, DK and NL. Studies had relevant limitations concerning the quality of execution and publication. Overall 13 of 24 studies reported a positive and two a negative effect of gatekeeping compared to open access models; nine showed no differences. The results varied according to outcome parameters. CONCLUSIONS: International evidence on effects of gatekeeping is limited by the low internal validity of studies and applicability to other contexts. It suggests that gatekeeping by PCP decreases utilization of specialist care and health care costs. Based on very few studies health outcomes and patient quality of life in gatekeeping models might be comparable with those in open access models. Evidence is inconsistent or not available concerning the quality of care, patient or provider satisfaction.


Asunto(s)
Control de Costos/economía , Control de Costos/métodos , Control de Acceso/estadística & datos numéricos , Costos de la Atención en Salud/estadística & datos numéricos , Medicina/estadística & datos numéricos , Evaluación de Resultado en la Atención de Salud/economía , Médicos de Atención Primaria/economía , Economía Médica/estadística & datos numéricos , Alemania , Rol del Médico
4.
Trans R Soc Trop Med Hyg ; 101(4): 317-25, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17084427

RESUMEN

Owing to increased epidemic activity and difficulties in controlling the insect vector, dengue has become a major public health problem in many parts of the tropics. The objective of this review is to analyse evidence regarding the achievements of community-based dengue control programmes. Medline, EMBASE, WHOLIS and the Cochrane Database of Systematic Reviews were searched (all to March 2005) to identify potentially relevant articles using keywords such as 'Aedes', 'dengue', 'breeding habits', 'housing' and 'community intervention'. According to the evaluation criteria recommended by the Cochrane Effective Practice and Organisation of Care Review Group, only studies that met the inclusion criteria of randomised controlled trials (RCT), controlled clinical trials (CCT), controlled before and after trials (CBA) or interrupted time series (ITS) were included. Eleven of 1091 studies met the inclusion criteria. Of these, two were RCTs, six were CBAs and three were ITS. The selected studies varied widely with respect to target groups, intervention procedures and outcome measurements. Six studies combined community participation programmes with dengue control tools. Methodological weaknesses were found in all studies: only two papers reported confidence intervals (95% CI); five studies reported P-values; two studies recognised the importance of water container productivity as a measure for vector density; in no study was cluster randomisation attempted; and in no study were costs and sustainability assessed. Evidence that community-based dengue control programmes alone and in combination with other control activities can enhance the effectiveness of dengue control programmes is weak.


Asunto(s)
Servicios de Salud Comunitaria/organización & administración , Dengue/prevención & control , Dengue/transmisión , Medicina Basada en la Evidencia , Humanos , Control de Insectos/métodos , Evaluación de Programas y Proyectos de Salud , Proyectos de Investigación
5.
Eur J Health Econ ; Suppl: 2-10, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16270212

RESUMEN

This article identifies and analyses a framework for "health baskets," the taxonomy of benefit catalogues for curative services, and the criteria for the in- or exclusion of benefits in nine EU member states (Denmark, England, France, Germany, Hungary, Italy, The Netherlands, Poland and Spain). Focusing on services of curative care, it is found that the explicitness of benefit catalogues varies largely between the countries. In the absence of explicitly defined benefit catalogues, in- and outpatient remuneration schemes have the character of benefit catalogues. The criteria for the in- or exclusion into benefit catalogues are often not transparent and (cost-)effectiveness is applied only for certain sectors. An EU-wide harmonization of benefit baskets does not seem realistic in the short or medium term as the variation in criteria and the taxonomies of benefit catalogues are large but not insurmountable. There may be scope for a European core basket.


Asunto(s)
Administración de los Servicios de Salud/clasificación , Servicios de Salud/clasificación , Programas Nacionales de Salud/clasificación , Programas Nacionales de Salud/organización & administración , Análisis Costo-Beneficio , Europa (Continente) , Política de Salud , Prioridades en Salud/clasificación , Prioridades en Salud/organización & administración , Servicios de Salud/legislación & jurisprudencia , Administración de los Servicios de Salud/legislación & jurisprudencia , Investigación sobre Servicios de Salud , Humanos , Programas Nacionales de Salud/legislación & jurisprudencia , Atención al Paciente/clasificación
6.
Internist (Berl) ; 45(10): 1189-95, 2004 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-15526176

RESUMEN

Expensive drugs are good value for money if they are effective and safe, and if they have a better cost-effectiveness ratio than the standard therapy. In this article, an overview of commonly used methods, sources and functions of health economic evaluation is presented and illustrated using clinical examples to facilitate interpretation of the health economic information.


Asunto(s)
Control de Costos/métodos , Análisis Costo-Beneficio/economía , Análisis Costo-Beneficio/métodos , Quimioterapia/economía , Quimioterapia/métodos , Costos de la Atención en Salud , Modelos Econométricos , Control de Costos/economía , Sistemas de Apoyo a Decisiones Clínicas , Alemania , Humanos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA